Maternal Antibodies Inhibit Neonatal and Infant Responses to Vaccination by Shaping the Early-Life B Cell Repertoire within Germinal Centers.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
13 08 2019
Historique:
received: 05 03 2019
revised: 01 07 2019
accepted: 15 07 2019
entrez: 15 8 2019
pubmed: 15 8 2019
medline: 5 9 2020
Statut: ppublish

Résumé

Maternal antibodies (MatAbs) protect offspring from infections but limit their responses to vaccination. The mechanisms of this inhibition are still debated. Using murine early-life immunization models mimicking the condition prevailing in humans, we observed the induction of CD4-T, T follicular helper, and germinal center (GC) B cell responses even when early-life antibody responses were abrogated by MatAbs. GC B cells induced in the presence of MatAbs form GC structures and exhibit canonical GC changes in gene expression but fail to differentiate into plasma cells and/or memory B cells in a MatAb titer-dependent manner. Furthermore, GC B cells elicited in the presence or absence of MatAbs use different V

Identifiants

pubmed: 31412246
pii: S2211-1247(19)30951-9
doi: 10.1016/j.celrep.2019.07.047
pii:
doi:

Substances chimiques

Antibodies 0
Antibodies, Viral 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1773-1784.e5

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Auteurs

Maria Vono (M)

WHO Collaborative Center for Vaccine Immunology, Department of Pathology and Immunology, University of Geneva, Geneva 1211, Switzerland. Electronic address: maria.vono@unige.ch.

Christiane Sigrid Eberhardt (CS)

WHO Collaborative Center for Vaccine Immunology, Department of Pathology and Immunology, University of Geneva, Geneva 1211, Switzerland.

Floriane Auderset (F)

WHO Collaborative Center for Vaccine Immunology, Department of Pathology and Immunology, University of Geneva, Geneva 1211, Switzerland.

Beatris Mastelic-Gavillet (B)

WHO Collaborative Center for Vaccine Immunology, Department of Pathology and Immunology, University of Geneva, Geneva 1211, Switzerland.

Sylvain Lemeille (S)

Department of Pathology and Immunology, University of Geneva, Geneva 1211, Switzerland.

Dennis Christensen (D)

Vaccine Adjuvant Research, Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen 2300, Denmark.

Peter Andersen (P)

Vaccine Adjuvant Research, Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen 2300, Denmark; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, 2300, Denmark.

Paul-Henri Lambert (PH)

WHO Collaborative Center for Vaccine Immunology, Department of Pathology and Immunology, University of Geneva, Geneva 1211, Switzerland.

Claire-Anne Siegrist (CA)

WHO Collaborative Center for Vaccine Immunology, Department of Pathology and Immunology, University of Geneva, Geneva 1211, Switzerland.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH